|Articles|December 1, 2007

Hepatitis C: Treatment Strategies to Maximize Outcomes
Volume 12
Issue 12 Suppl

Making It Happen: Managed Care Considerations in Vanquishing Hepatitis C

Author(s)John G. McHutchison, MD, Bruce R. Bacon, MD, Glenda S. Owens, RPh, MHA, CDM

Download PDF: Making It Happen: Managed Care Considerations in Vanquishing Hepatitis C

Articles in this issue

over 18 years ago

Article

Participating Faculty

over 18 years ago

Article

Introduction

over 18 years ago

Article

Into the Light: Strategies for Battling Hepatitis C

over 18 years ago

Article

CME/CE POSTTEST

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Making It Happen: Managed Care Considerations in Vanquishing Hepatitis C

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Lilly Expands Retatrutide Access Amid Doctor Pushback

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

CANN Responds to HRSA's Revised 340B Rebate Model Pilot

Infection Remains a Major Burden in Blood Cancers

Setting Treatment Goals in RA: Remission, Joint Damage, and Systemic Risk

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Making It Happen: Managed Care Considerations in Vanquishing Hepatitis C

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Lilly Expands Retatrutide Access Amid Doctor Pushback

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

CANN Responds to HRSA's Revised 340B Rebate Model Pilot

Infection Remains a Major Burden in Blood Cancers

Setting Treatment Goals in RA: Remission, Joint Damage, and Systemic Risk